Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more MINNEAPOLIS, MINNESOTA / ACCESSWIRE / January 10, 2025 / Pace® Life Sciences, LLC, a U.S.-b ...
A Creation Story" streaming for the first time on the Documentary Channel.NORTHAMPTON, MA / ACCESSWIRE / January 10, 2025 / GoDaddy Originally ...
Bolstered by new alliances and continued Samsung synergies supporting its "Consumer Experiences. Automotive Grade" value proposition, HARMAN redefines ...
KuCoin, a leading global cryptocurrency exchange, is excited to share the findings from its second edition of the KuCoin ...
Las Vegas SandsNORTHAMPTON, MA / ACCESSWIRE / January 10, 2025 / The 2024 Sands Cares Global Hygiene Kit Build achieved a major milestone in Sands' decade-long partnership with Clean the World and its ...
Platform builds on Quinyx's Frontline Portal, offering significant user experience enhancements for frontline workers BOSTON, MASSACHUSETTS / ACCESSWIRE / January 10, 2025 / Quinyx, a leading provider ...
A closely watched report released by the Labor Department on Friday showed employment in the U.S. increased by much more than expected in the month of December.The Labor ...
NEW YORK CITY, NY / ACCESSWIRE / January 10, 2025 / EquityMultiple, a premier real estate investment platform, today released its 2025 Commercial Real Estate (CRE) Market Outlook, presenting a forward ...
TAMPA, FLORIDA / ACCESSWIRE / January 10, 2025 / As the medical industry adapts to rapid regulatory changes, operational challenges, and evolving patient expectations, Black Book Research has identifi ...
Customer returns inspection, grading, refurbishment, and recovery all in one state of the art returns processing center. DALLAS, TEXAS / ACCESSWIRE / January 10, 2025 / Back-Track and Image Microsyste ...
NORTHAMPTON, MA / ACCESSWIRE / January 10, 2025 / When it comes to laboratory environments, safety is paramount. Antea Group ...
OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of allergic reactions (incl. anaphylaxis) and is based on the proprietary AmorphOX® technology.The clinical ...